Legislation has been introduced in the U.S. House of Representatives and U.S. Senate that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens. The bills would require any health plan that provides coverage for cancer chemotherapy treatment to provide coverage for orally administered and self-injectable anticancer medications at a cost no less favorable than the cost of IV, port administered, or injected anticancer medications.
In the House of Representatives, Representatives Brian Higgins (D-NY) and Peter King (R-NY) have introduced the Cancer Drug Coverage Parity Act (H.R. 1801). Similar legislation, the Cancer Treatment Parity Act (S. 1879), has been introduced in the Senate by Senators Franken (D-MN) and Mark Kirk (R-IL).
Your Senators and Representative need to cosponsor these bills in order for them to be considered by the full Congress. Please take a moment to send an e-mail to your Senators and Representative by clicking on the "Take Action" link below.
|* Please note that ASH has transitioned to a new e-Advocacy platform. If you currently have an ASH account, your e-Advocacy login will be your e-mail address and your password will be the word "grassroots" - upon your first login you will be requested to change your password. If you do not have an ASH account you can create an e-Advocacy account after you click "Take Action" above. IF you encounter any issues, please contact ASH Policy and Practice Coordinator Patrick C. Irelan at email@example.com.